These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26327235)

  • 1. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease.
    Montine TJ; Monsell SE; Beach TG; Bigio EH; Bu Y; Cairns NJ; Frosch M; Henriksen J; Kofler J; Kukull WA; Lee EB; Nelson PT; Schantz AM; Schneider JA; Sonnen JA; Trojanowski JQ; Vinters HV; Zhou XH; Hyman BT
    Alzheimers Dement; 2016 Feb; 12(2):164-169. PubMed ID: 26327235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.
    Hyman BT; Phelps CH; Beach TG; Bigio EH; Cairns NJ; Carrillo MC; Dickson DW; Duyckaerts C; Frosch MP; Masliah E; Mirra SS; Nelson PT; Schneider JA; Thal DR; Thies B; Trojanowski JQ; Vinters HV; Montine TJ
    Alzheimers Dement; 2012 Jan; 8(1):1-13. PubMed ID: 22265587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the condensed protocol for the NIA-AA guidelines for the neuropathological assessment of Alzheimer's disease in an academic clinical practice.
    Bharadwaj R; Cimino PJ; Flanagan ME; Latimer CS; Gonzalez-Cuyar LF; Juric-Sekhar G; Montine TJ; Marshall DA; Keene CD
    Histopathology; 2018 Feb; 72(3):433-440. PubMed ID: 28815699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of a Condensed Protocol That Reduces Effort and Cost of NIA-AA Guidelines for Neuropathologic Assessment of Alzheimer Disease.
    Flanagan ME; Marshall DA; Shofer JB; Montine KS; Nelson PT; Montine TJ; Keene CD
    J Neuropathol Exp Neurol; 2017 Jan; 76(1):39-43. PubMed ID: 28062571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.
    Montine TJ; Phelps CH; Beach TG; Bigio EH; Cairns NJ; Dickson DW; Duyckaerts C; Frosch MP; Masliah E; Mirra SS; Nelson PT; Schneider JA; Thal DR; Trojanowski JQ; Vinters HV; Hyman BT; ;
    Acta Neuropathol; 2012 Jan; 123(1):1-11. PubMed ID: 22101365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease-related plaques in nondemented subjects.
    Elobeid A; Rantakömi S; Soininen H; Alafuzoff I
    Alzheimers Dement; 2014 Sep; 10(5):522-9. PubMed ID: 24742915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.
    Beach TG; Monsell SE; Phillips LE; Kukull W
    J Neuropathol Exp Neurol; 2012 Apr; 71(4):266-73. PubMed ID: 22437338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do NIA-AA criteria distinguish Alzheimer's disease from frontotemporal dementia?
    Harris JM; Thompson JC; Gall C; Richardson AM; Neary D; du Plessis D; Pal P; Mann DM; Snowden JS; Jones M
    Alzheimers Dement; 2015 Feb; 11(2):207-15. PubMed ID: 25022535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Jack CR; Albert MS; Knopman DS; McKhann GM; Sperling RA; Carrillo MC; Thies B; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):257-62. PubMed ID: 21514247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Preclinical" AD revisited: neuropathology of cognitively normal older adults.
    Schmitt FA; Davis DG; Wekstein DR; Smith CD; Ashford JW; Markesbery WR
    Neurology; 2000 Aug; 55(3):370-6. PubMed ID: 10932270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria.
    Carrillo MC; Dean RA; Nicolas F; Miller DS; Berman R; Khachaturian Z; Bain LJ; Schindler R; Knopman D;
    Alzheimers Dement; 2013 Sep; 9(5):594-601. PubMed ID: 24007744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Education, cognitive function, and severity of neuropathology in Alzheimer disease.
    Koepsell TD; Kurland BF; Harel O; Johnson EA; Zhou XH; Kukull WA
    Neurology; 2008 May; 70(19 Pt 2):1732-9. PubMed ID: 18160675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical neuropathology practice news 3-2012: the "ABC" in AD-revised and updated guideline for the neuropathologic assessment of Alzheimer's disease.
    Kovacs GG; Gelpi E
    Clin Neuropathol; 2012; 31(3):116-8. PubMed ID: 22551914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participants.
    Franklin EE; Perrin RJ; Vincent B; Baxter M; Morris JC; Cairns NJ;
    Alzheimers Dement; 2015 Jul; 11(7):815-22. PubMed ID: 26194314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.
    Garrett MD; Valle R
    Dementia (London); 2016 Mar; 15(2):239-54. PubMed ID: 24662500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Utility of the National Alzheimer's Coordinating Center's Database for the Rapid Assessment of Evolving Neuropathologic Conditions.
    Mock C; Teylan M; Beecham G; Besser L; Cairns NJ; Crary JF; Katsumata Y; Nelson PT; Kukull W
    Alzheimer Dis Assoc Disord; 2020; 34(2):105-111. PubMed ID: 32304374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"?
    McRae-McKee K; Udeh-Momoh CT; Price G; Bajaj S; de Jager CA; Scott D; Hadjichrysanthou C; McNaughton E; Bracoud L; Ahmadi-Abhari S; de Wolf F; Anderson RM; Middleton LT;
    Alzheimers Dement; 2019 Oct; 15(10):1348-1356. PubMed ID: 31564609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease.
    Alexopoulos P; Roesler J; Thierjung N; Werle L; Buck D; Yakushev I; Gleixner L; Kagerbauer S; Ortner M; Grimmer T; Kübler H; Martin J; Laskaris N; Kurz A; Perneczky R
    Eur Arch Psychiatry Clin Neurosci; 2016 Oct; 266(7):587-97. PubMed ID: 26253588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease.
    Visser PJ; Vos S; van Rossum I; Scheltens P
    Alzheimers Dement; 2012 Nov; 8(6):560-3. PubMed ID: 23102126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.